NOT KNOWN DETAILS ABOUT SEMAGLUTUDE WEEKS 13-16 BUNDLE

Thyroid C-mobile Tumors: In rodent research, semaglutide continues to be shown to induce thyroid C-mobile tumors. It can be not known whether or not this threat relates to people, but semaglutide is contraindicated in people with a personal or household historical past of medullary thyroid carcinoma (MTC) or individuals with Numerous Endocrine Neop